Member Info for Joner

They have posted yesterday on both LinkedIn and twitter that they are there - so not sure what this faux outrage is about

You mean Stephen Moon sold ~45% of his holding right?

They were effectively up for sale during the strategic review, in the last 12 months! Profitability has been just on the horizon for years but never quite get there before more dilution.

When the offer comes it would be sold, they need the THG scale.

I see Thg are spoiling themselves with Christmas acquisitions in the Beauty space.

Would SiS make a nice stocking-filler for MyProtein?

For my take, locality (50mins up the road), current pricing and synergies all stack up nicely, but then I thought that this was prime for take over pre PhD.

Why are you back in? Yesterday you forecast a fall to £2.10?

Don’t be silly, Directors bought 10000 shares Sang not £10k the new chair bought 18k shares. The extra shares issued for the purchase was

Crikey Koru kids worth ~0.1% of the gross portfolio, Forward cost ~3% of the gross portfolio . I’m sorry I really can’t get too excited about this.

So in summary this has become too high risk for you personally Sang?

Honestly squealing over the tiny investment that is Koru kids, which had fair value cut in Forwards interims anyway and having an institutional investor like blackrock onboard is myopic at best

The shares that have been issued have bought Forward’s assets at a deep discount to NAV(is that really dilution!) and the cash raised through equity issue is being used to further invest into existing assets and further new opportunities.

Some of the comments here read like the cash raised is being used to prop up a failing business which really is not the case.

I’m happy with today’s news - bought assets that they’ve had visibility over for some time at a large discount to NAV.

Raised cash to INVEST into assets new and existing opportunities. For me dilution is a problem where the funds aren’t being used to invest but rather to keep a business going - which isn’t the case here.

KBW what would be your investment case to invest here?

I contacted investor relations email a while back to get a copy of the report which they used to cite in Rns to bench mark the brand awareness and so on - I never got a copy because it was confidential - but the point is Stephen replied to the investor relations email - if that helps

I thought looking at LinkedIn a couple of months ago he’d had a major accident on his bike 15 fractures and a damaged lung - I don’t know how strava works, maybe someone else is on the bike or he’s still in recovery?

I know old news from our point of view, but Costain have today posted on LinkedIn the detail of the recent collaboration with VRS.

Interesting new acquisition - great to see the ambition for the company.

MM’s LinkedIn post gives some additional background.

Low Ball offer rebuffed. Not sure why some people don’t get it?

Pathetic

£2.12 final offer. 25% uplift on the £1.70.

Getting it at a steal for that.